BRAF V600E MUTATIONS IN METASTATIC MELANOMA - CASE REPORT
| Autor: | Aleksandar Martinovic, Miloš Bracanović, Gordana Pupic, Zorka Inic, Ivana Inic, Momcilo Inic, Miomir Šašić, Milan Žegarac |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2014 |
| Předmět: |
Oncology
medicine.medical_specialty Metastatic melanoma treatment business.industry lcsh:R lcsh:Medicine BRAF V600 mutation medicine.disease Industrial and Manufacturing Engineering BRAF V600E Clinical study Internal medicine Female patient BRAF V600 Mutation medicine Carcinoma business Vemurafenib Survival rate neoplasms medicine.drug metastatic melanoma |
| Zdroj: | Acta Medica Medianae, Vol 53, Iss 3, Pp 39-41 (2014) |
| ISSN: | 1821-2794 0365-4478 |
| Popis: | The treatment of metastatic melanoma represents a challenge. Vemurafenib, a selective BRAF kinase inhibitor, is a new medicine against carcinoma. Recently, it has been shown that it raises the survival rate among patients with metastatic melanoma who have BRAFV600mutation. This work will discuss new approaches to the treatment of patients with metastatic melanoma, who have been proved to have BRAF V600 mutation and we will present the case of a female patient with whom the clinical study with Vemurafenib has been started. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|